Cholinesterase Inhibitors

Cholinesterase inhibitors are a class of drugs used to treat conditions, such as Alzheimer’s disease and other forms of dementia, that are associated with cognitive decline. These medications work by inhibiting the enzyme acetylcholinesterase, thereby indirectly raising levels of the neurotransmitter acetylcholine that are known to be depleted in certain neurodegenerative disorders. Cholinesterase inhibitors are thought to counteract the effects of dementia by slowing the degradation of the neurotransmitter and restoring balance to its levels in affected brain regions. The most common cholinesterase inhibitors used to treat dementia are donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne). These drugs have been shown to produce modest improvements in cognitive symptoms, such as memory and decision-making, in individuals with Alzheimer’s and other related conditions. Donepezil is the most widely used of the three and it is typically administered once daily at a standard dose of 10mg. It is important to understand, however, that despite the benefits of cholinesterase inhibitors, there can be significant side effects associated with their use. Commonly reported side effects include nausea, vomiting, diarrhea, and fatigue. In some patients, these symptoms may be made worse by concurrent use of other medications, specifically antidepressants, which can interact with certain cholinesterase inhibitors and inhibit their effectiveness. Thus, while cholinesterase inhibitors may provide a temporary reversal of some of the cognitive impairments associated with dementia, it is important to discuss potential side effects and other risks with a physician before beginning this treatment. It is also advisable to avoid taking other medications in combination with this class of drugs, as this may increase the risk of adverse effects.